Background: Acute abdominal pain is among the most common reasons for visits to a pediatric emergency department. A major diagnostic challenge is distinguishing abdominal pain that requires surgical intervention from conditions that can be managed medically. Objectives: This study aimed to evaluate the final diagnoses of children presenting with acute abdominal pain at the emergency department of Mofid Children’s Hospital in Tehran, Iran. Methods: This retrospective cross-sectional study included 200 children with acute abdominal pain who presented to Mofid Children’s Hospital, Tehran, Iran, between January and March 2021. Data were extracted from medical records under a waiver of informed consent approved by the institutional ethics committee. Patients were categorized into medical and surgical treatment groups. Demographic, clinical, and diagnostic variables were compared using SPSS version 27, and P < 0.05 was considered statistically significant. Results: Of 200 children, 40 (20.0%) underwent surgery, whereas 160 (80.0%) received medical treatment only. The overall mean age was 6.99 ± 2.64 years, and 41.0% of the participants were male; no significant differences in age or sex were observed between the groups. The most common final diagnosis was gastroenteritis (50.5%), followed by appendicitis (13.5%) and constipation (8.0%). Among surgically managed cases, appendicitis accounted for 67.5%, whereas gastroenteritis was the most common diagnosis in the medical group (63.1%). Conclusions: Most cases of pediatric acute abdominal pain in this study were managed medically; however, a substantial proportion required timely surgical evaluation. Accurate history taking, a thorough physical examination, and appropriate diagnostic investigations remain essential for determining the optimal management pathway.
Background and Aims: Multisystem inflammatory syndrome in children (MIS‐C) is a post‐infectious inflammatory condition associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that can affect multiple organ systems. Data comparing clinical features and outcomes between MIS‐C patients with and without laboratory evidence of coronavirus disease 2019 (COVID‐19) remain limited. Methods: This retrospective observational study was conducted at Mofid Children's Hospital, a pediatric referral center in Tehran, Iran, between March 2020 and July 2021. Children diagnosed with MIS‐C based on World Health Organization (WHO) criteria were included and classified into groups with and without laboratory evidence of SARS‐CoV‐2 infection according to PCR and/or IgG serology results. Demographic data, clinical manifestations, laboratory and imaging findings, treatments, and outcomes were compared between the groups using univariate and multivariable analyses. A p ‐value < 0.05 was considered statistically significant. Results: A total of 121 patients with MIS‐C were included, of whom 44 (36.4%) had laboratory evidence of SARS‐CoV‐2 infection. The mean age was 4.74 ± 3.99 years, and 61.2% were male. ICU admission occurred in 21.5% and mortality was 2.5%. In univariate analysis, fever during the first 24 h of hospitalization and antiviral use were more frequent in the group with laboratory evidence, whereas conjunctivitis and elevated C‐reactive protein levels were more common among the group without laboratory evidence; however, CRP did not differ significantly between groups when analyzed as a continuous variable. In multivariable analysis, fever during the first 24 h of hospitalization was the only variable associated with laboratory evidence of SARS‐CoV‐2 infection (aOR 2.57; 95% CI 1.05–6.30; p = 0.040). Conclusion: MIS‐C presents with broad and largely overlapping clinical, laboratory, and imaging features regardless of SARS‐CoV‐2 laboratory status, and the few observed differences were exploratory and of limited discriminative value. These findings highlight the importance of considering MIS‐C even in the absence of laboratory confirmation of SARS‐CoV‐2 infection.